New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Third Quarter 2017 Financial Results
November 07, 2017 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Satellite Healthcare
Satellite Healthcare to Present at American Society of Nephrology Annual Kidney Week Conference
October 31, 2017 09:03 ET | Satellite Healthcare
SAN JOSE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today announced it will present three posters and host a NephTalk lounge for...
Satellite Healthcare
Satellite Healthcare Awards $800,000 in Applied Pragmatic Clinical Research Grants
October 04, 2017 15:42 ET | Satellite Healthcare
SAN JOSE, Calif., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today awarded $800,000 in Applied Pragmatic Clinical Research Grants to four...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at the Baird 2017 Global Healthcare Conference September 7, 2017
September 05, 2017 07:45 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Second Quarter 2017 Financial Results
August 07, 2017 17:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Closing of $22 Million Convertible Preferred Stock Financing
August 02, 2017 19:30 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces $22.0 Million Private Placement
June 22, 2017 09:31 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st
June 15, 2017 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., June 15, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
GMILogo_Vertical-Gradient.png
Medical Fluid Bags Market to cross $4 billion by 2024: Global Market Insights, Inc.
June 13, 2017 05:30 ET | Global Market Insights, Inc
Ocean View, Delaware, June 13, 2017 (GLOBE NEWSWIRE) -- The Industry growth report “Medical Fluid Bags Market  By Product (Blood Bags, Intravenous Bags, Drain Bags [Surgical, Urinary], Enema...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces First Quarter 2017 Financial Results
May 10, 2017 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney...